MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$34,449K
Net loss
-$28,354K
Deemed dividend
-$5,775K
Dividend on series l
preferred stock
-$320K
Total other income
(expense), net
-$15,932K
Loss from operations
-$12,422K
Change in fair value of
greenshoe rights...
-$11,413K
Gain on settlement of
vendor payable
$998K
Change in fair value of
warrant liability
-$241K
Other
$156K
Interest income
$123K
Loss on initial
recognition of greenshoe...
$28,736K
Selling, general and
administrative (including...
$8,950K
Research and development
$3,472K
Interest expense
$127K
Back
Back
Income Statement
source: myfinsight.com
GT Biopharma, Inc. (GTBP)
GT Biopharma, Inc. (GTBP)